09:00–09:40 | Keynote address—Darren Treanor, Consultant Histopathologist & Honorary Clinical Associate Professor, Leeds Teaching Hospitals NHS Trust and University of Leeds
10:15–10:45 | Keynote address—Speaker TBC
13:15–14.15 |Daljeet Bansal, NPIC Operations Director, Leeds Teaching Hospitals NHS Trust, UK
09:00–09.40 | Keynote address—Paul Van Diest, Professor of Pathology, Head of Department of Pathology University Medical Center Utrecht, The Netherlands
The possibilities of AI in pathology seem to be unlimited, and all over the world many research groups are developing useful algorithms. Further, many startup companies are trying to market algorithms. Nevertheless, implementation into daily practice seems to be lagging behind dramatically. In this presentation, current status of implementation of AI in pathology will be reviewed and implementation hurdles will be discussed.
12:00–12.25 | Kevin Sandeman, Department Manager, Pathology Dept, Region Skåne, Sweden
Artificial intelligence (AI) holds immense potential, with numerous AI-based products on the market. However, the application of AI in clinical pathology is limited, with AI algorithms demonstrating local success. There is a need for clinical validation to ensure patient safety and clinical effectiveness. Because many regions lack the resources for
the validation process, a national cooperation with a national database is crucial for sharing resources. Our solution established a pilot for a national platform that guarantees validation capacity and facilitates safe and effective clinical implementation of AI solutions. As a first clinical question automated Ki67-calculation in breast cancer is addressed as it promises both a reduction of interobserver variation and a shorter average time for calculation by the pathologist.
15:05–15.30 | Sonali Natu, Consultant Cellular Pathologist, Tees Valley Pathology Services and Clinical Lead for Pathology, North East and North Cumbria
Laboratory Accreditation is an integral part of providing high quality services. Implementation of digital pathology technology falls within the scope of accreditation. The talk will summarise where we are at now with this process and where we need to go with it. Vendors of digital pathology platform and potentially AI applications have to be engaged with this process to ensure the use of technology is regulated and meets the standards required for providing high quality services.